全美最富华裔医生大手笔 一口气收购加州六家医院

2017-07-10 老任 人民网

美国华文媒体报道,被称为“美国最富有医生”的企业家黄馨祥(Patrick Soon-Shiong)在加州收购了六间医院,这是他首度涉足医院经营事业。

美国华文媒体报道,被称为“美国最富有医生”的企业家黄馨祥(Patrick Soon-Shiong)在加州收购了六间医院,这是他首度涉足医院经营事业。

这次他以南坦集团(NantWorks)名义收购了四间在北加州和两间在南加州的医院,包括洛杉矶历史最悠久的圣文森医疗中心(St. Vincent Medical Center)。收购手续正在在完成,并于是乎日对外公佈收购案,相关细节皆保密。

黄馨祥拥有多重身份,除了是外科医生,也是医疗学者、企业家和慈善家。他还是Tronc Inc.传媒集团主要股东,该集团旗下有《洛杉矶时报》和《芝加哥论坛报》。医疗传媒STAT指出,黄馨祥将翻新这些医院设备,加强癌症、器官移植、整形外科、心脏疾病等医疗服务,未来更可能引进他在医疗方面的投资,包括癌症疗法、医疗软件,甚至是"GPS"癌症研究定位技术等。

附:
黄馨祥1952年出生于中医世家,父母本是中国南方的乡村医生,为躲避战乱,二战期间移民到了南非。黄馨祥靠奖学金在南非约翰内斯堡念完医学院,24岁获得了该校医学博士学位。作为在南非种族隔离时代成长的中国移民之子,身为黄种人的黄馨祥受到白人占主导的南非医学界的排挤。他的第一位白人病人曾拒绝他的治疗。

1980年,28岁的南非屌丝黄馨祥来到洛杉矶开始他人生的新阶段。1983年,他成为UCLA(加州大学洛杉矶分校)医学院的教授,并在34岁那年进行了学校第一例胰腺器官移植,挽救了一名糖尿病患者的生命。此时的黄馨祥小有名气,再也不是当年那个被病人歧视的南非屌丝了。但是和他未来的成就比起来,此时的他不过是从南非屌丝升级成了美国屌丝而已。

1991年,胸怀大志的美国屌丝黄馨祥离开学校创立了一家糖尿病药品公司VivoRx,以便把自己的糖尿病疗法推向市场。但是很快,他的眼光就瞄准了抗肿瘤药物。

1994年,美国著名篮球巨星魔术师约翰逊用1000万美金买下洛杉矶湖人队4.5%的股份,而屌丝陈颂雄则把眼光瞄准治疗乳腺癌的药物Abraxane。这种药比全球最畅销的治癌药物紫杉醇(Taxol)药效更强,更少副作用。开发新药需要大量的资金支持,医学出身的陈颂雄展现了惊人的商业天赋和胆识,他没有引入风险投资这一传统的渠道为Abraxane的研发提供资金,而是贷款收购一家仿制药小型上市公司后将其更名,然后在该公司开展Abraxane研发。这家公司就是美国屌丝陈颂雄1997年创立的美国药品伙伴公司(American Pharmaceutical Partners,APP)。在大多数人只会埋头做科研的科学家群体中,美国屌丝陈颂雄显然展现了一般科研人员不具备的金融高富帅的潜质。

2005年,Abraxane获得美国食品药品管理局批准使用,摆脱屌丝身份的曙光终于出现了。

2007年,他的金融高富帅的潜质又一次展现。在金融风暴到来之前,他以56亿美元的高价把APP制药卖给Fresenius公司,他从中净赚30亿美元!屌丝一夜逆袭,挤身全美富豪榜。2007年的福布斯美国富豪榜中他排名第117,当时估计身价为30亿美元。

2010年,以29亿美元把从APP剥离的Abraxis生物科学公司卖给Celgene公司。两次交易让陈颂雄身价暴涨。2010年黄馨祥以55亿美元的身家名列《福布斯》全美富豪榜第60名,登上洛杉矶首富的宝座。

黄馨祥2010年还顺手买下了当年魔术师约翰逊在湖人队的股份,成为湖人队的小股东。如果梦想成为亿万富翁的人们希望从黄馨祥的故事中学到点东西,他们应该留心,在谈判桌上他是如何比其他人更好地理解生物制药产业的价值,以及各个产业是如何更好的互补。当然,黄馨祥在科研以及商业上的天赋明显优于一般人。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1683328, encodeId=d840168332801, content=<a href='/topic/show?id=40c23592e38' target=_blank style='color:#2F92EE;'>#华裔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35927, encryptionId=40c23592e38, topicName=华裔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6527955805, createdName=qblt, createdTime=Fri Oct 20 17:21:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221035, encodeId=260322103535, content=学习过了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue Jul 11 11:41:44 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220767, encodeId=af5a220e670b, content=写的是黄馨祥,怎么出来个陈颂雄?走点心吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3buhru0LAsyg84LKFlUu9TbQzMqdkJrVdYDBNWQleZia9xknRyucu90N0HziaMyKJeyiaOt0pxKZsg/132, createdBy=38e21963843, createdName=大黑牛, createdTime=Mon Jul 10 17:38:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220735, encodeId=b71f220e35b3, content=走出去的中国人, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:19:09 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220729, encodeId=914c220e29fc, content=真的富有, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1e2042632, createdName=ZCYY落枫, createdTime=Mon Jul 10 14:00:06 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220691, encodeId=63c622069155, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Jul 10 10:31:09 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-10-20 qblt
  2. [GetPortalCommentsPageByObjectIdResponse(id=1683328, encodeId=d840168332801, content=<a href='/topic/show?id=40c23592e38' target=_blank style='color:#2F92EE;'>#华裔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35927, encryptionId=40c23592e38, topicName=华裔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6527955805, createdName=qblt, createdTime=Fri Oct 20 17:21:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221035, encodeId=260322103535, content=学习过了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue Jul 11 11:41:44 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220767, encodeId=af5a220e670b, content=写的是黄馨祥,怎么出来个陈颂雄?走点心吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3buhru0LAsyg84LKFlUu9TbQzMqdkJrVdYDBNWQleZia9xknRyucu90N0HziaMyKJeyiaOt0pxKZsg/132, createdBy=38e21963843, createdName=大黑牛, createdTime=Mon Jul 10 17:38:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220735, encodeId=b71f220e35b3, content=走出去的中国人, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:19:09 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220729, encodeId=914c220e29fc, content=真的富有, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1e2042632, createdName=ZCYY落枫, createdTime=Mon Jul 10 14:00:06 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220691, encodeId=63c622069155, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Jul 10 10:31:09 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-11 明天会更好!

    学习过了,谢谢分享!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1683328, encodeId=d840168332801, content=<a href='/topic/show?id=40c23592e38' target=_blank style='color:#2F92EE;'>#华裔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35927, encryptionId=40c23592e38, topicName=华裔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6527955805, createdName=qblt, createdTime=Fri Oct 20 17:21:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221035, encodeId=260322103535, content=学习过了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue Jul 11 11:41:44 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220767, encodeId=af5a220e670b, content=写的是黄馨祥,怎么出来个陈颂雄?走点心吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3buhru0LAsyg84LKFlUu9TbQzMqdkJrVdYDBNWQleZia9xknRyucu90N0HziaMyKJeyiaOt0pxKZsg/132, createdBy=38e21963843, createdName=大黑牛, createdTime=Mon Jul 10 17:38:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220735, encodeId=b71f220e35b3, content=走出去的中国人, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:19:09 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220729, encodeId=914c220e29fc, content=真的富有, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1e2042632, createdName=ZCYY落枫, createdTime=Mon Jul 10 14:00:06 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220691, encodeId=63c622069155, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Jul 10 10:31:09 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-10 大黑牛

    写的是黄馨祥,怎么出来个陈颂雄?走点心吧

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1683328, encodeId=d840168332801, content=<a href='/topic/show?id=40c23592e38' target=_blank style='color:#2F92EE;'>#华裔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35927, encryptionId=40c23592e38, topicName=华裔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6527955805, createdName=qblt, createdTime=Fri Oct 20 17:21:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221035, encodeId=260322103535, content=学习过了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue Jul 11 11:41:44 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220767, encodeId=af5a220e670b, content=写的是黄馨祥,怎么出来个陈颂雄?走点心吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3buhru0LAsyg84LKFlUu9TbQzMqdkJrVdYDBNWQleZia9xknRyucu90N0HziaMyKJeyiaOt0pxKZsg/132, createdBy=38e21963843, createdName=大黑牛, createdTime=Mon Jul 10 17:38:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220735, encodeId=b71f220e35b3, content=走出去的中国人, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:19:09 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220729, encodeId=914c220e29fc, content=真的富有, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1e2042632, createdName=ZCYY落枫, createdTime=Mon Jul 10 14:00:06 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220691, encodeId=63c622069155, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Jul 10 10:31:09 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-10 zhangyou

    走出去的中国人

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1683328, encodeId=d840168332801, content=<a href='/topic/show?id=40c23592e38' target=_blank style='color:#2F92EE;'>#华裔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35927, encryptionId=40c23592e38, topicName=华裔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6527955805, createdName=qblt, createdTime=Fri Oct 20 17:21:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221035, encodeId=260322103535, content=学习过了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue Jul 11 11:41:44 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220767, encodeId=af5a220e670b, content=写的是黄馨祥,怎么出来个陈颂雄?走点心吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3buhru0LAsyg84LKFlUu9TbQzMqdkJrVdYDBNWQleZia9xknRyucu90N0HziaMyKJeyiaOt0pxKZsg/132, createdBy=38e21963843, createdName=大黑牛, createdTime=Mon Jul 10 17:38:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220735, encodeId=b71f220e35b3, content=走出去的中国人, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:19:09 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220729, encodeId=914c220e29fc, content=真的富有, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1e2042632, createdName=ZCYY落枫, createdTime=Mon Jul 10 14:00:06 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220691, encodeId=63c622069155, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Jul 10 10:31:09 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-10 ZCYY落枫

    真的富有

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1683328, encodeId=d840168332801, content=<a href='/topic/show?id=40c23592e38' target=_blank style='color:#2F92EE;'>#华裔#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35927, encryptionId=40c23592e38, topicName=华裔)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a6527955805, createdName=qblt, createdTime=Fri Oct 20 17:21:00 CST 2017, time=2017-10-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=221035, encodeId=260322103535, content=学习过了,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160914/IMG57D82E721DB581755.jpg, createdBy=4fc81933929, createdName=明天会更好!, createdTime=Tue Jul 11 11:41:44 CST 2017, time=2017-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220767, encodeId=af5a220e670b, content=写的是黄馨祥,怎么出来个陈颂雄?走点心吧, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83er3buhru0LAsyg84LKFlUu9TbQzMqdkJrVdYDBNWQleZia9xknRyucu90N0HziaMyKJeyiaOt0pxKZsg/132, createdBy=38e21963843, createdName=大黑牛, createdTime=Mon Jul 10 17:38:36 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220735, encodeId=b71f220e35b3, content=走出去的中国人, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b77a1758618, createdName=zhangyou, createdTime=Mon Jul 10 14:19:09 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220729, encodeId=914c220e29fc, content=真的富有, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a1e2042632, createdName=ZCYY落枫, createdTime=Mon Jul 10 14:00:06 CST 2017, time=2017-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=220691, encodeId=63c622069155, content=非常好的文章,学习了,很受益, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Mon Jul 10 10:31:09 CST 2017, time=2017-07-10, status=1, ipAttribution=)]
    2017-07-10 天涯183

    非常好的文章,学习了,很受益

    0

相关资讯

2014年全球收购大戏频出 重磅药会去哪儿

早春2月全球第三大仿制药商阿特维斯宣布,计划耗资约250亿美元收购森林实验室,以扩大品牌药产品组合,并增强其在美国的市场。这是进入2014年以来,制药企业最大的一桩计划收购案,消息一出引起市场强烈反应。通过此次大手笔的收购,阿特维斯可以增加其在中枢系统、心血管系统及呼吸道系统等领域的产品研发。并购虽说对企业而言是皆大欢喜的事情,但是对被收购企业的重磅产品的未来走向却很少有人关注。 早春2月全球第

艾伯维550亿美元收购Shire

艾伯维(AbbVie)7月18日与英国制药商夏尔(Shire)达成收购协议,耗资约550亿美元收购后者,该笔交易预计将于今年第四季度完成。此次收购,源于美国医疗保健公司积极寻求收购海外竞争对手,以便在一定程度上降低税率。AbbVie最初于2014年5月向Shire提出了现金和股票收购提议,之后数次提高报价至490亿美元,但遭Shire拒绝。 双方周五表示,将在Shire的总部——英国泽西

强生300亿美元收购欧洲很大生物制药公司Actelion 开辟罕见病治疗领域

通过这笔交易,强生将在自身免疫疾病、心脏病、癌症等领域外,再度成为一个新疾病领域的领导者。

大塚制药斥资35亿美元收购美国药企Avanir

日本大塚控股旗下大塚制药宣布,将斥资约35亿美元收购美国药企Avanir Pharmaceuticals ,以壮大其神经疾病药物品类。大塚制药将每股支付17美元现金,相当于较Avanir周一收盘价溢价13.3%。 该收购发起之际,大塚制药正面临其精神分裂症药物Abilify将在2015年4月专利到期的不利局面。 Avanir称,大塚制药将在10个工作日内发起收购要约,以购买Avanir全部

又一家公立医院被收购了!

又一家医院被卖,卖了3.4亿元。11月12日上午,存在了近60年的鄂钢医院再次易主,被一家药企以3.4亿元的价格收购,实现了国企医院身份的转变。鄂钢医院的卖出,意味着鄂州又一家医院被并购,这也在医疗界引发了广泛热议。据《医学界》了解,此前,鄂州市第二医院曾以5000万元被整体转让,卖给了浙江私人老板(浙江尼尔迈特集团)。今年8月份,鄂州二院再次被卖,以3.6亿元的价格被济民制药收购。时至今日,鄂钢

不畏挫折!Juno收购Redox再出发

近段时间,Juno公司因为其临床实验中患者死亡问题被推上了风口浪尖。这一研究让外界对CAR-T疗法的安全性产生了不小的质疑。令Juno公司庆幸的是,尽管发生了这一不幸事件,FDA经过审慎考虑后还是批准其ROCKET临床试验可以继续进行。这项2期临床试验旨在通过CAR-T疗法,治疗复发性或难治性的B细胞急性淋巴细胞白血病。 然而,这一挫折并未让这个CAR-T巨头停下脚步。公司最近宣布已经收购